OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting metastatic cancer
Karuna Ganesh, Joan Massagué
Nature Medicine (2021) Vol. 27, Iss. 1, pp. 34-44
Open Access | Times Cited: 686

Showing 1-25 of 686 citing articles:

New approaches and procedures for cancer treatment: Current perspectives
Dejene Tolossa Debela, Seke GY Muzazu, Kidist Digamo Heraro, et al.
SAGE Open Medicine (2021) Vol. 9
Open Access | Times Cited: 850

The inflammatory pathogenesis of colorectal cancer
Mark R. Schmitt, Florian R. Greten
Nature reviews. Immunology (2021) Vol. 21, Iss. 10, pp. 653-667
Closed Access | Times Cited: 441

Liquid Biopsy: From Discovery to Clinical Application
Catherine Alix‐Panabières, Klaus Pantel
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 858-873
Open Access | Times Cited: 357

EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
Mary Luz Uribe, Ilaria Marrocco, Yosef Yarden
Cancers (2021) Vol. 13, Iss. 11, pp. 2748-2748
Open Access | Times Cited: 308

Metastasis
Stefanie Gerstberger, Qingwen Jiang, Karuna Ganesh
Cell (2023) Vol. 186, Iss. 8, pp. 1564-1579
Open Access | Times Cited: 293

Metastasis-Initiating Cells and Ecosystems
Joan Massagué, Karuna Ganesh
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 971-994
Open Access | Times Cited: 228

The role of lipids in cancer progression and metastasis
Miguel Martı́n-Pérez, Uxue Urdiroz-Urricelqui, Claudia Bigas, et al.
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1675-1699
Open Access | Times Cited: 221

Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution
Dian Yang, Matthew G. Jones, Santiago Naranjo, et al.
Cell (2022) Vol. 185, Iss. 11, pp. 1905-1923.e25
Open Access | Times Cited: 200

Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 199

Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance
Xiaowei Liu, Jinen Song, Hao Zhang, et al.
Cancer Cell (2023) Vol. 41, Iss. 2, pp. 272-287.e9
Open Access | Times Cited: 168

Biology, vulnerabilities and clinical applications of circulating tumour cells
Alexander Ring, Bich Doan Nguyen-Sträuli, Andreas Wicki, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 2, pp. 95-111
Open Access | Times Cited: 155

Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges
Francisco Rodríguez, Pablo Caruana, Noa De la Fuente, et al.
Biomolecules (2022) Vol. 12, Iss. 6, pp. 784-784
Open Access | Times Cited: 131

TGF-β in developmental and fibrogenic EMTs
Jun Ho Lee, Joan Massagué
Seminars in Cancer Biology (2022) Vol. 86, pp. 136-145
Open Access | Times Cited: 127

Cancer cell plasticity during tumor progression, metastasis and response to therapy
Andrea Pérez-González, Kevin Bévant, Cédric Blanpain
Nature Cancer (2023) Vol. 4, Iss. 8, pp. 1063-1082
Open Access | Times Cited: 117

Insights on functionalized carbon nanotubes for cancer theranostics
Lu Tang, Qiaqia Xiao, Yijun Mei, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 109

Cancers make their own luck: theories of cancer origins
Amir Jassim, Eric P. Rahrmann, Benjamin D. Simons, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 10, pp. 710-724
Open Access | Times Cited: 96

Cancer treatment therapies: traditional to modern approaches to combat cancers
Rasanpreet Kaur, Alok Bhardwaj, Saurabh Gupta
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9663-9676
Closed Access | Times Cited: 91

Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance
Thais Pereira‐Veiga, Svenja Schneegans, Klaus Pantel, et al.
Cell Reports (2022) Vol. 40, Iss. 9, pp. 111298-111298
Open Access | Times Cited: 89

Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity
Ryan C. Gimple, Kailin Yang, Matthew Halbert, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 9, pp. 497-514
Closed Access | Times Cited: 81

Overview and countermeasures of cancer burden in China
Yian Wang, Qijia Yan, Chunmei Fan, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 11, pp. 2515-2526
Open Access | Times Cited: 65

Nanoparticle-mediated cancer cell therapy: basic science to clinical applications
Jaya Verma, Caaisha Warsame, Rajkumar Kottayasamy Seenivasagam, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 601-627
Open Access | Times Cited: 51

From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression
Riya Thapa, Obaid Afzal, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154959-154959
Closed Access | Times Cited: 45

New insights into the correlations between circulating tumor cells and target organ metastasis
Qinru Zhan, Bixia Liu, Xiaohua Situ, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 42

A review of the role of carbon nanotubes for cancer treatment based on photothermal and photodynamic therapy techniques
Mohammed Faiad Naief, Samar Naser Mohammed, Hadil Jubair Mayouf, et al.
Journal of Organometallic Chemistry (2023) Vol. 999, pp. 122819-122819
Closed Access | Times Cited: 38

Page 1 - Next Page

Scroll to top